In this study, we evaluated the prognostic performance of two methods for assessing IGF2BP3 gene expression, one based on protein quantification (IHC) and the other on mRNA quantification (RT-qPCR) in the same cohort of melanoma patients. Here, IGF2BP3 is linked to melanoma.